Navigation Links
Albany College of Pharmacy Researcher Receives $368,445 Grant from the National Institutes of Health

Dr. Shaker A. Mousa to Test New Approaches to Stop the Spread of Pancreatic


ALBANY, N.Y., June 26 /PRNewswire/ -- Shaker A. Mousa, Ph.D., executive vice president and chairman of the Pharmaceutical Research Institute (PRI) at Albany College of Pharmacy (ACP), has been awarded a $368,445 research grant from the National Cancer Institute, part of the National Institutes of Health. Dr. Mousa along with a team of PRI investigators that includes Dr. Lawrence Lansing, Dr. Lakshman Sehgal, Dr. Murat Yalcin and PRI technical staff, will study new methods for limiting the spread of pancreatic cancer in the body to allow for better treatment of the disease. The research will take place over a period of 22 months.

Cancer cells survive and spread (metastasize) by attaching themselves to platelets in the bloodstream. Research has shown that the blood thinner Heparin is effective in preventing the bonding of cancer cells and platelets, but the dosages required to affect this result lead to increased bleeding or blood loss in patients. Dr. Mousa and his team will focus their research on modifying 'low molecular weight Heparin compounds' in a way that will still inhibit the bonding of the cancer cells and platelets, while minimizing or eliminating the bleeding and other negative side effects associated with high levels of Heparin.

"Pancreatic cancer is not only hard to diagnose, but it is an extremely aggressive form of cancer. Surgeons rarely operate on patients with pancreatic cancer when metastasis is taking place as the surgery tends to accelerate the spread of the cancer," said Dr. Mousa. "If we can keep the cancer cells from attaching to the platelets, we can isolate them in the body. They can then be killed fairly easily by the patient's own immune system or through low levels of chemotherapy. Once that happens, physicians will have a significantly better opportunity to treat the cancer and extend the patient's life."

The Pharmaceutical Research Institute at ACP is dedicated to cutting-edge research, pharmaceutical services and education. PRI's drug discovery efforts focus on angiogenesis, thrombosis and vascular disorders. The Institute is also playing a leading role in the development of nanopharmaceutical technology.

The entire research project is being funded with federal money.

About Albany College of Pharmacy

Founded in 1881, Albany College of Pharmacy is a private, independent institution dedicated to the improvement of health. The College has educational programs and research activities spanning the full spectrum of pharmacy and health sciences - from drug discovery and development to patient counseling and health care to studying health outcomes. More than 1,400 ACP students are pursuing a wide range of career pathways in the health care field through degree programs in pharmacy, pharmaceutical sciences, biomedical technology and health and human sciences.

SOURCE Albany College of Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
2. Albert Einstein College of Medicine Receives $25-Million Gift to Support Stem Cell and Epigenomic Research and Clinical Skills Training
3. World Debut for BSPs HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
4. Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
5. CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session
6. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
7. Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
8. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
9. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
10. KGI and Smith College Establish Leadership Forum for Women in Bioscience
11. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
Post Your Comments:
(Date:10/10/2017)... 2017 International research firm Parks Associates announced today ... the TMA 2017 Annual Meeting , October 11 in ... home security market and how smart safety and security products impact the ... Parks Associates: Smart Home Devices: ... "The residential security market has experienced ...
(Date:10/10/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... October 10, ... ... risk management, technological innovation and business process optimization firm for the life sciences ... the BoxWorks conference in San Francisco. , The presentation, “Automating GxP ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
(Date:10/9/2017)... , ... October 09, 2017 , ... At its national ... Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has been ... a member of the winning team for the 2015 Breakthrough Prize in Fundamental physics ...
Breaking Biology Technology:
(Date:6/30/2017)... Today, American Trucking Associations announced Seeing ... and eye tracking software, became the newest member ... "Artificial intelligence and advanced sensing algorithms ... driver,s attentiveness levels while on the road.  Drivers ... fatigue and prevent potential accidents, which could lead ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
Breaking Biology News(10 mins):